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Thioredoxin-Interacting Protein (Txnip) is an important regulator of glucose metabolism and func-
tions by inhibiting cellular glucose uptake. The expression of the Txnip gene is sensitive to glucose
availability and is negatively correlated with the glycolytic rate. Here we show that hypoxia induces
a rapid decrease in Txnip mRNA and protein expression in a Hypoxia-Inducible Factor independent
manner. Hypoxia caused reduced binding of the glucose responsive MondoA:Mlx transcription fac-
tor to the carbohydrate response elements (ChoREs) in the Txnip promoter. Our data suggest that
hypoxia decreases MondoA:Mlx activity by increasing glycolytic ﬂux, leading to the depletion of gly-
colytic intermediates which normally activate MondoA:Mlx. Hypoxia dependent Txnip down-regu-
lation may be an important compensatory mechanism through which cancer cells adapt their
metabolism to low oxygen concentrations.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Thioredoxin-Interacting Protein (Txnip) is an important regula-
tor of cellular glucose and fatty acid metabolism in both humans
and mice [1–4]. It has been identiﬁed as one of the genes most po-
tently upregulated by glucose [5]. Upon glucose stimulation, the
expression of the Txnip gene is induced by the tetrameric Mond-
oA:Mlx transcription factor complex containing two MondoA and
two Max-like protein X (Mlx) proteins, which bind to two carbohy-
drate response elements (ChoREs) in the TXNIP promoter [6,7]. The
MondoA:Mlx complex is activated in response to elevated glucose
concentrations and is translocated into the nucleus where it binds
to ChoREs and induces gene expression of glucose regulated genes.
However, the exact molecular mechanism through which elevated
glucose concentrations activate the MondoA:Mlx transcription fac-
tor is currently unknown. Upon induction by MondoA:Mlx, the
Txnip protein functions to inhibit cellular glucose uptake and
metabolism and promote fatty acid utilization. The role of the
Txnip protein in regulating glucose metabolism is apparent fromchemical Societies. Published by E
Biochemistry, National Uni-
. Luo), bchth@nus.edu.sg
of California San Diego, 3855the hypoglycaemic phenotype observed in Txnip knockout mice,
which is a consequence of increased peripheral glucose disposal
and reduced hepatic gluconeogenesis [8–10].
In normal cells the majority of cellular ATP is produced via oxi-
dative phosphorylation (OXPHOS) in mitochondria. In cancer cells,
switching of ATP production from OXPHOS to aerobic glycolysis oc-
curs and this phenomenon is termed the Warburg effect. One
important mediator of the Warburg effect is the transcription fac-
tor Hypoxia-Inducible Factor (HIF) [11]. HIF is known as the master
regulator of the cellular hypoxic response and functions as a het-
erodimer consisting of a hypoxia inducible a-subunit (HIF-1a
and HIF-2a) and a constitutively expressed b-subunit (HIF-1b)
[12]. The HIF-1a and HIF-2a proteins are regulated at the level of
their protein stability in an oxygen dependent manner. In nor-
moxia either of two conserved proline residues (Pro402 and Pro564
in HIF-1a) is hydroxylated by a HIF prolyl hydroxylase (PHD)
enzyme. This hydroxylation reaction requires molecular oxygen
as well as the PHD cosubstrates and cofactors 2-oxoglutarate, iron
and ascorbate. Upon hydroxylation, HIF-1a and HIF-2a bind to the
von Hippel Lindau (VHL) E3 ubiquitin ligase, which mediates the
ubiquitination of the HIF-1a and HIF-2a proteins, thus targeting
them for 26S proteasome dependent degradation. In hypoxia,
PHD activity is inhibited due to the lack of oxygen, resulting in
HIF-1a and HIF-2a stabilization and transactivation of HIF target
genes that mediate the adaptation of cells to low oxygen concen-
trations. One important adaptive mechanism is the upregulation
of aerobic glycolysis as a result of transactivation of glucoselsevier B.V. All rights reserved.
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OXPHOS via upregulation of pyruvate dehydrogenase kinase-1
[11,13,14]. HIF is frequently upregulated in cancer as a conse-
quence of the inherently low oxygen concentrations in tumor tis-
sue or as a result of genetic changes, for instance mutations in
the VHL gene or activation of Akt/mTOR signaling. These ﬁndings
have led to the hypothesis that HIF plays an important role in
the Warburg effect in cancer cells [15].
Interestingly, several studies have demonstrated that Txnip
expression is suppressed in cancer cells [16–19] and Txnip deﬁ-
cient mice have been reported to have a dramatically increased
incidence of hepatocellular carcinoma [20]. Furthermore, over-
expression of Txnip has been reported to inhibit cell proliferation
and promote cell death in pancreatic b-cells [6]. Therefore it has
been suggested that Txnip functions as a tumor suppressor [20].
Given the inherently low oxygen concentrations in tumors and
the important role of Txnip in regulating cellular glucose utiliza-
tion, we hypothesized that Txnip expression is suppressed in
hypoxia to promote increased cellular glucose uptake and utiliza-
tion. In this report, we demonstrate that Txnip expression is mark-
edly down-regulated in hypoxia. This effect is HIF independent, but
mediated via a hypoxia induced increase in the glycolytic rate. Our
results reveal a novel mechanism through which hypoxia signals to
regulate gene expression. We suggest that hypoxia dependent
Txnip down-regulation may be an important compensatory mech-
anism through which cancer cells adapt their metabolism to low
oxygen concentrations.
2. Materials and methods
2.1. Cell culture
Cells were cultured in DMEM (Invitrogen) supplemented
with 10% fetal bovine serum (HyClone), L-glutamine (Invitro-
gen) and penicillin/streptomycin (Invitrogen) at 5%CO2 in
37 C.
2.2. DNA constructs
The Txnip reporter plasmid, in which the Txnip promoter region
corresponding to 269 to 63 (containing two ChoREs) was in-
serted upstream of the ﬁreﬂy luciferase gene, was described in
Ref. [21]. The pGL3-HRE plasmid, containing three copies of the hy-
poxia-response element from the phosphoglycerate kinase pro-
moter was a gift from Dr. Kaye Williams (University of
Manchester, UK).
2.3. Western blotting
Cells were lysed with lysis buffer (25 mM Tris–HCl pH 7.5,
100 mM NaCl, 2.5 mM EDTA and EGTA, 20 mM NaF, 1 mM
Na3VO4, 20 mM Na b-glycerophosphate, 10 mM Na pyrophos-
phate, 0.5% Triton X-100, 0.1% b-mercaptoethanol and protease
inhibitor cocktail (Roche)). Proteins were resolved by SDS–PAGE
and were transferred into nitrocellulose membrane (GE Health-
care). Antibodies used were Txnip JY-2 (MBL International), HIF-
1a (BD Bioscience), a-tubulin antibody (Invitrogen), aldolase A
(Cell Signalling Technology) and p60/sti (described in Ref. [22]).
All Western blot results are representative of at least two individ-
ual experiments.
2.4. Reporter assays
Cells were transfected with luciferase reporter plasmids
using GeneJuice Transfection Agent (Novagen). Treatment of cellswas carried out for the last four hours. Cells were lysed in
Steady-Glo Luciferase Assay System (Promega) and the luciferase
activity was measured using a 20/20n Luminometer (Turner
Biosystems).
2.5. RNA extraction and real-time PCR
RNA extraction was carried out using the RNeasy Mini Kit
(Qiagen). Genomic DNA was removed with the on-column
RNase-Free DNase kit (Qiagen). RNA samples were reverse-
transcribed into cDNA using SuperScript III, dNTP and random
hexamers in the presence of RNaseOUT (all from Invitrogen). cDNA
was diluted and quantiﬁed by real-time PCR which was performed
with the KAPA SYBR FAST qPCR MasterMix (Kapa Biosystems) and
7300 real-time PCR system (Applied Biosystems). b-Actin gene was
used as a control. Primers were synthesized by 1st Base (Singa-
pore). The real-time PCR primer sequences can be found in Ref.
[23].
2.6. Chromatin immunoprecipitation (ChIP) assays
Treated cells were ﬁxed with formaldehyde (ﬁnal concentration
of 1%) for 10 min at room temperature, followed by the addition of
glycine (ﬁnal concentration of 100 mM) to stop the ﬁxation. The
cells were washed twice with phosphate-buffered saline and har-
vested in MC buffer [24]. Sonication was then carried out, followed
by immunoprecipitation using the ChIP assay kit (Millipore) to-
gether with the indicated antibodies (see Ref. [14]). DNA fragments
were then puriﬁed using the QIAquick PCR Puriﬁcation Kit (Qiagen)
followed by quantitative real-time PCR targeting the human Txnip
promoter. The primer sequences for the ChIP assays can be found
in Ref. [21].
2.7. siRNA-mediated gene silencing
siRNA duplexes were transfected at ﬁnal concentrations of
20 nM using Lipofectamine RNAiMax transfection reagent (Invitro-
gen) for 3 days. The aldolase A siRNA nucleotide sequences were
CCGAGAACACCGAGGAGAAdTdT (AldolaseA #1) and GGAAGAAG-
GAGAACCUGAAdTdT (AldolaseA #2).
2.8. Hypoxia incubations
Hypoxia incubations were carried out at a controlled oxygen
tension (1%) using a Pro-ox 110 oxygen controller and Pro-ox
in vitro chamber (BioSpherix, Redﬁeld, NY).
2.9. Measurement of the lactate concentration in the medium
Cell culture medium was collected from cells after various
treatments for lactate measurement. Sample (50 ll) was mixed
with 50 mM Tris pH 7.5 buffer and 7.5 mM NAD (Sigma). Reaction
was started by adding 1 ll lactate dehydrogenase enzyme (Sigma).
The lactate concentration was measured spectrophotometrically as
the increase in absorbance at 340 nm.
2.10. Measurement of glucose in the medium
Medium was collected from cells after various treatments for
glucose content determination. Media sample (1 ll) was mixed
with 1 PBS, 2 mM NADP (Sigma), 2 mM ATP and 10 mM MgCl2.
The reaction was started by adding 1 unit of enzyme hexokinase/
G6PDH (Sigma). Enzyme activity was measured spectrophotomet-
rically as the increase in absorbance at 340 nm.
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3.1. Hypoxia down-regulates Txnip protein expression independent
from proteasomal degradation
To examine the effect of hypoxia on Txnip protein expression,
HeLa cells and HEK293 cells were treated under hypoxic (1% oxy-
gen) conditions for 4 h. Western blot analysis of endogenous Txnip
indicated that in both cell lines the protein was signiﬁcantly de-
creased as compared to cells incubated in normoxia (Fig. 1A).
Reoxygenation of the HeLa cells for 30 min at 21% oxygen resulted
in partial recovery of the Txnip expression (Fig. 1B). Of note, a
slower migrating form of Txnip whose relative abundance was in-
creased in hypoxia was detected in some experiments in both HeLa
and HEK293 cells. This band likely represents a post-translationally
modiﬁed, e.g., phosphorylated form of Txnip. However, the exact
nature of this modiﬁcation and its signiﬁcance for Txnip protein
function and regulation is currently not clear.
The Txnip protein is known to be highly unstable and regulated
by the ubiquitin–proteasome system [25]. To investigate whether
the down-regulation of Txnip under hypoxia is due to increased
proteasomal degradation, HEK293 cells were treated with MG-
132, an inhibitor of the 26S proteasome, under both normoxic
and hypoxic conditions. As expected, the Txnip protein was stabi-
lized in normoxia when MG-132 was present. When cells were ex-
posed to hypoxia, Txnip protein concentrations were reduced to a
similar degree in the absence versus the presence of proteasomeTxnip
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Fig. 1. Hypoxia down-regulates Txnip protein expression independent from
proteasomal degradation. Western blots were used to determine the Txnip protein
expression after 4 h of hypoxic incubation (1% oxygen). HEK293 (A) and HeLa (B)
cells were incubated under hypoxic conditions for 4 h followed by 30 min of
reoxygenation (B). (C) HEK293 cells were treated for 4 h in hypoxia with or without
20 lm of proteasome inhibitor MG-132.inhibitor (Fig. 1C). This result suggested that the decrease in Txnip
protein expression is not due to effects on protein stability.
3.2. Inhibition of Txnip protein expression in hypoxia is due to reduced
mRNA transcription
To determine whether hypoxia regulates Txnip at the level of its
mRNA expression, quantitative real-time PCR was carried out to
measure the Txnip mRNA concentration in cells after 4 h of hypox-
ia treatment. Txnip mRNA expression was found to be decreased
by 96% after hypoxia treatment (Fig. 2A, compare Columns 1 and
6).
We subsequently investigated whether hypoxia compromised
the recruitment of MondoA:Mlx to the ChoRE sites in the Txnip
promoter, leading to transcriptional repression. Thus, HeLa cells
were subjected to hypoxia treatment for 4 h followed by chroma-
tin-immunoprecipitation (ChIP) assays. Our results indicated that
the occupancy of MLX on the Txnip promoter was reduced under
hypoxic conditions (Fig. 2C). A similar decrease was observed for
RNA polymerase II (Pol II), while the recruitment of nuclear factor
Y (NF-Y) to CCAAT boxes and the acetylation status of histone H3
(AcH3) on the Txnip promoter were not signiﬁcantly changed
(Fig. 2C). These results further indicate that the downregulation
of Txnip in hypoxia is due to reduced mRNA transcription.
3.3. Hypoxia dependent regulation of Txnip mRNA expression is
independent of HIF
The transcription factor HIF is the major mediator of the cellular
response to hypoxia. To investigate whether the effect of hypoxia
on Txnip mRNA expression is dependent on HIF, several hypoxia-
mimetic agents that are known to stabilize HIF in normoxia were
used. Hypoxia-mimetic drugs inhibit PHD activity to promote sta-
bilization of the HIF-1a and HIF-2a subunit even when oxygen is
present. Desferrioxamine (DFO) acts by chelating the iron in the
PHD active site which is required for PHD function while cobalt
chloride (CoCl2) likely competes with iron for the iron-binding site
in the enzyme. Dimethyloxalylglycine (DMOG) is a 2-oxoglutarate
analog which inhibits the PHD activity by competing with the PHD
cosubstrate 2-oxoglutarate. To activate HIF dependent transcrip-
tion in normoxia, we also used HIF-1a with alanine substitutions
of proline residues 402 and 564 (P402A and P564A) (mutHIF-1a).
These mutations lead to constitutive expression of the protein in
normoxia by preventing PHD dependent hydroxylation and conse-
quently VHL mediated degradation of HIF-1a. When measuring the
effect of the various treatments on Txnip mRNA expression in HeLa
cells, we observed that in contrast to hypoxia, cells incubated in
normoxia after transfection of mutHIF-1a or treatment with DFO
and CoCl2 did not show a signiﬁcant decrease in the Txnip mRNA
expression (Fig. 2A). Only DMOG treated cells exhibited a 62% de-
crease in the Txnip mRNA concentration.
We also determined the effect of hypoxia-mimetic agents and
mutHIF-1a transfection on Txnip protein concentrations. As shown
in Fig. 3A, while hypoxia treatment led to markedly decreased
Txnip protein expression, there was no signiﬁcant decrease in the
Txnip protein level when HIF-1a was induced with CoCl2 or DFO.
Similarly, transfection of mutHIF-1a did not result in a reduced
Txnip protein concentration (Fig. 3B). Consistent with the mRNA
results, only treatment with DMOG caused a reduction in Txnip
protein levels (Fig. 3A). Treatment with all three hypoxia mimetics
and transfection of mutHIF-1a resulted in HIF-1a accumulation
that was comparable to hypoxia induced HIF-1a expression
(Fig. 3A and B). In contrast to DMOG, DFO and CoCl2 are less spe-
ciﬁc and may exert pleiotropic effects. Thus, it is possible that their
inhibitory effect on Txnip expression is masked by a concomitant
induction of Txnip via a PHD and HIF independent mechanism.
Fig. 2. Inhibition of Txnip protein expression in hypoxia is due to reduced mRNA transcription (A) Txnip mRNA expression was measured using quantitative Real-Time PCR.
HeLa cells were transfected with P402A/P564A mutant HIF-1a (mutHIF-1a), dominant-negative HIF-1a (dnHIF-1a), or PHD2, where indicated. After 2 days, cells were treated
in hypoxia (1%) or in the presence various hypoxia-mimetic agents for 4 h followed by quantitative real-time PCR. (B) HeLa cells were transfected with pGL3-HRE reporter
plasmid and cotransfected with dnHIF-1a, PHD2 or empty vector, as indicated, followed by hypoxic incubation. (C) HeLa cells were treated for 4 h under hypoxia followed by
ChIP assay using antibodies against Mlx, RNA Polymerase II (Pol II), Acetylated Histone 3 (AcH3), and Nuclear Factor Y subunit A (NFYA). The occupancy on Txnip promoter
was determined by quantitative real-time PCR, as described in Section 2. The results in (C) represent the average of three independent experiments (±S.D.), in (A) and (B)
representative experiments are shown.
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or CoCl2. Thus, if DFO and CoCl2 exert a HIF independent stimula-
tory effect on Txnip expression, inhibition of Txnip expression by
DMOG would be reversed. However, as shown in Fig. 3A, cotreat-
ment with DFO or CoCl2 had no effect on DMOG mediated Txnip
suppression. In conclusion, our results indicate that there is no cor-
relation between the HIF-1a activity and Txnip mRNA expressionwith the exception of the hypoxia mimetic drug DMOG. These re-
sults suggest a HIF independent regulatory mechanism.
We also inhibited HIF function in hypoxia by transfecting cells
with dominant-negative HIF-1a (dnHIF-1a) or PHD2. dnHIF-1a
lacks the oxygen-dependent degradation domain and C-terminal
transactivation in HIF-1a and is therefore unable to bind to the
p300 transcriptional coactivator and promote transactivation of
Fig. 3. Hypoxia dependent regulation of Txnip expression is independent of HIF. (A)
HeLa cells were treated in hypoxia or in the presence of hypoxia-mimetic drugs
(200 lM CoCl2, 200 lM desferrioxamine (DFO), or 2 mM dimethyloxalylglycine
(DMOG)) for 4 h, followed by Western blot analysis of cell lysates using the
indicated antibodies. (B) Cells were transfected with mutHIF-1a, dnHIF-1a, or PHD2
and treated for 4 h in hypoxia as indicated. (C) VHL deﬁcient 786-O cells were
treated under hypoxic conditions for 4 h with or without 0.5 mM of iodoacetate
(IA). Txnip mRNA expression was determined using quantitative real-time PCR, as
described in Section 2.
Fig. 4. Inhibition of glycolytic enzymes results in the induction of Txnip mRNA
expression. (A) HeLa cells were treated in hypoxia or with 2 mM DMOG in the
presence or absence of 0.5 mM iodoacetate for 4 h. Txnip mRNA level was measured
by quantitative real-time PCR. (B) Aldolase expression was silenced in HEK293T
cells using siRNA for three days, followed by 4 h of hypoxic treatment and
measurement of Txnip mRNA expression. Knock-down of aldolase protein expres-
sion was conﬁrmed using Western blotting as shown in the lower panel. P60/Sti
served as loading control. The results in (A) correspond to the average of three
independent experiments (±S.D.), in (B) one representative experiment is shown.
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the nucleus. This truncated protein therefore competes with
endogenous HIF-1a for binding to HIF-1b. Over-expression of
PHD2, the major PHD isoform responsible for HIF-1a hydroxyl-
ation, is expected to downregulate HIF-1a in hypoxia. By using Hy-
poxia-Response-Element (HRE) dependent luciferase reporter
assays, we conﬁrmed that transfection of dnHIF-1a and PHD2 in-
deed resulted in the inhibition of HIF transcriptional activity
(Fig. 2B). As expected, luciferase expression was markedly in-
creased in hypoxia. Induction of HIF dependent reporter activity
in hypoxia was reversed when dnHIF-1a and PHD2 were transfec-
ted into cells.
We then determined the effect of inhibiting HIF in hypoxia on
Txnip expression. Transfecting cells with dnHIF-1a or PHD2 didnot reverse hypoxia induced Txnip mRNA down-regulation
(Fig. 2A). Inhibition of HIF function with dnHIF-1a or PHD2 trans-
fection was also without effects on Txnip protein expression
(Fig. 3B). These results further conﬁrm that there is no correlation
between the HIF-1a activity and Txnip expression, suggesting that
Txnip downregulation in hypoxia is HIF independent.
We also used VHL deﬁcient 786-O cells to conﬁrm that hypoxia
dependent Txnip regulation is HIF independent. VHL deﬁcient 786-
O cells do not express HIF-1a and the HIF-2a protein is constitu-
tively expressed and not induced under hypoxic conditions. We
observed that even when oxygen dependent regulation of HIF is
prevented, hypoxia still caused a decrease in Txnip mRNA expres-
sion in VHL deﬁcient cells (Fig. 3C).
3.4. Hypoxia down-regulates Txnip expression by increasing glycolytic
ﬂux and decreasing critical glycolytic intermediates
Our results indicate that hypoxia downregulates both mRNA
and protein expression of Txnip in a manner that is dependent
on the MondoA:Mlx complex, but independent of the HIF tran-
scription factor. Thus, hypoxia may exert a direct regulatory effect
on MondoA:Mlx activity. Of note, we have recently reported that
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mediated Txnip expression via a mechanism that involves an in-
crease in the rate of glycolysis [26]. This is likely to cause depletion
of a critical metabolite(s) that mediates glucose dependent
MondoA:Mlx activation. One cellular consequence of hypoxia is
inhibition of cytochrome c oxidase and OXPHOS. We thus hypoth-
esized that hypoxia may inhibit Txnip expression via a similar
mechanism. To test this hypothesis, we initially measured rates
of cellular glucose consumption and lactate production. Thus, HeLa
cells were incubated after addition of fresh medium overnight un-
der hypoxic conditions or in the presence of the OXPHOS inhibitor
myxothiazol and the glucose and lactate concentrations in the cell
culture medium were measured. A marked decrease in the med-
ium glucose concentration in hypoxia (60.5%) and myxothiazol
(40.7%) treated cells compared to the untreated cells was observed.
The lactate concentrations in the medium of cells treated in hypox-
ia or in the presence of myxothiazol were 0.22 mM and 0.38 mM,
respectively, which are both higher compared to untreated cells
(0.16 mM). Thus, as expected, cells exposed to a hypoxic environ-
ment exhibit increased rates of aerobic glycolysis in order to main-
tain cellular ATP concentrations.
To further test the hypothesis that increased glycolytic ﬂux is
responsible for the effect of hypoxia on Txnip, we used the GAPDH
inhibitor iodoacetate to allow accumulation of glycolytic interme-
diates. HeLa cells were treated with 0.5 mM of iodoacetate under
hypoxia and DMOG treatment. Interestingly, the hypoxia depen-
dent down-regulation of Txnip mRNA expression was completely
prevented by iodoacetate, while the inhibitor had no signiﬁcant ef-
fect on Txnip mRNA concentrations in normoxia (Fig. 4A). Iodoac-
etate also inhibited the hypoxia dependent downregulation of
Txnip mRNA in 786-O cells (Fig. 3C). Interestingly, iodoactetate
also reversed the effect of DMOG (Fig. 4A), suggesting that hypoxia
and DMOG function via a related mechanism. These results suggest
that metabolites upstream of GAPDH play an important role in the
induction of Txnip expression, and depletion of these metabolites
as a result of OXPHOS inhibition in hypoxia and a compensatory in-
crease in glycolysis may lead to Txnip down-regulation.
To conﬁrm our results with the glycolysis inhibitor iodoacetate,
we used siRNA to silence the expression of aldolase, which is posi-
tioned immediately upstream of GAPDH in the glycolytic cascade.
Our results indicate that the knock down of aldolase expression in
HeLa cells partially rescued the downregulation of Txnip mRNA in
hypoxia (Fig. 4B). This further suggests that the presence of mole-
cules upstream of aldolase in the glycolytic cascade is required to
induce the expression of Txnip.1.00 0.23 0.10
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Fig. 5. Inhibition of Txnip in hypoxia is transient. HeLa cells were treated in hypoxia
for 2, 4, 6, 8 and 16 h. Txnip mRNA expression was measured by quantitative real-
time PCR. The results shown correspond to one representative experiment.3.5. Inhibition of Txnip in hypoxia is transient
It has been reported by Le Jan et al. [26] and Baker et al. [27]
that hypoxia upregulates Txnip expression in a HIF-dependent
manner. To investigate the basis for the contrasting effects of hy-
poxia on Txnip expression, we incubated cells for different time-
periods under hypoxia followed by real-time PCR to determine
the Txnip mRNA levels. As shown in Fig. 5, Txnip mRNA level is
markedly reduced at the early time-points and showed a maximal,
10-fold inhibitory effect at 4 h of hypoxic incubation. Thereafter,
Txnip mRNA expression increased and was markedly elevated after
16 h of hypoxic incubation (12-fold increase compare to nor-
moxia). This suggests that the hypoxia-induced downregulation
of Txnip expression is transient.4. Discussion
In this study, we tested the hypothesis that hypoxia down-reg-
ulates Txnip expression, which would result in increased glucose
uptake and utilization to maintain the cellular energy homeostasis.
Our results demonstrate for the ﬁrst time that incubation of cells in
hypoxia leads to a rapid and marked down-regulation of Txnip
mRNA and protein expression. Furthermore, our results indicate
that hypoxia dependent Txnip down-regulation is likely due to
inhibition of gene transcription. Hypoxia was found to inhibit
MondoA:Mlx occupancy at the Txnip promoter, suggesting that
low oxygen concentrations inhibit MondoA:Mlx activity. Mon-
oA:Mlx activity is known to be tightly regulated by glucose and
this effect is mediated via glycolytic intermediates, such as glu-
cose-6-phosphate [7]. Our previous results have shown that inhib-
itors of OXPHOS suppress Txnip expression by increasing cellular
rates of glycolysis [26]. This likely results in depletion of a critical
glycolytic intermediate (e.g., glucose-6-phosphate) that normally
mediates glucose dependent Txnip expression. We have previously
suggested that the regulation of MondoA:Mlx activity and Txnip
expression by the glycolytic rate as opposed to the glucose avail-
ability is an important regulatory mechanism of the cellular energy
metabolism [28]. Thus, increased rates of glycolysis, as observed
under hypoxia, lead to reduced Txnip expression, thus promoting
cellular glucose uptake to increase substrate availability for glycol-
ysis. In contrast, low rates of glycolysis would result in high Txnip
expression, thus inhibiting glucose uptake under conditions where
cellular demand for glucose is low.
Interestingly, we found that hypoxia dependent Txnip suppres-
sion is HIF independent. This result is surprising, given that HIF
functions as a master regulator of the cellular adaptation to low
oxygen concentrations. Thus, our results reveal that cells are able
to sense oxygen tension via HIF independent pathways, by
responding to hypoxia induced increases in the glycolytic rate. Hy-
poxia dependent Txnip regulation is likely of signiﬁcance in tu-
mors. Oxygen supply gradually decreases down a gradient within
the tumor tissue. Under these conditions, mitochondrial function
and OXPHOS are partially inhibited, resulting in cellular depen-
dency on high glycolytic rates to generate sufﬁcient ATP. Inhibition
of Txnip expression may thus contribute to the metabolic adapta-
tion of tumor cells. Although the observed inhibitory effect of hy-
poxia on Txnip mRNA concentrations was transient (see Fig. 5),
tumors are frequently exposed to intermittent hypoxia and there-
fore, the novel mechanism identiﬁed in this study is still likely to
be important for cancer cells to adjust their metabolism to chang-
ing environmental conditions.
In summary, our results reveal a novel mechanism through
which cells adjust their metabolism in response to hypoxia and
demonstrate that cells are able to sense cellular oxygen concentra-
tions via HIF and prolyl hydroxylase independent mechanisms. Our
498 T.F. Chai et al. / FEBS Letters 585 (2011) 492–498results are likely to be signiﬁcant for future work in targeting the
glycolytic pathway and Txnip expression in cancer.
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